Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells

Journal of Endocrinology

Volumn 208, Issue 2, 2011, Pages 161-169

  Wang, Qidi ^a   Cai, Ying ^a   Van De Casteele, Mark ^a   Pipeleers, Daniel ^a   Ling, Zhidong ^a,b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b Shanghai Clinical Center for Endocrine and Metabolic Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ELONGATION FACTOR 2; GLIBENCLAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; PROTEIN; PROTEIN S6; RAPAMYCIN; RP 8 BROMO CYCLIC AMP; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; INSULIN SYNTHESIS; NONHUMAN; PANCREAS ISLET BETA CELL; PHARMACODYNAMICS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; TRANSLATION INITIATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CARRIER PROTEINS; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG INTERACTIONS; ENZYME ACTIVATION; GLUCOSE; GLYBURIDE; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; METFORMIN; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; RATS; RATS, WISTAR; RIBOSOMAL PROTEIN S6; SIGNAL TRANSDUCTION; THIONUCLEOTIDES; TOR SERINE-THREONINE KINASES;

EID: 78951489223     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0372     Document Type: Article

References (46)

1. Arsham AM & Neufeld TP 2006 Thinking globally and acting locally with TOR. Current Opinion in Cell Biology 18 589-597. (doi:10.1016/j.ceb.2006.09. 005)
2. Bolster DR, Crozier SJ, Kimball SR & Jefferson LS 2002 AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. Journal of Biological Chemistry 277 23977-23980. (doi:10.1074/jbc.C200171200)
3. Browne GJ & Proud CG 2002 Regulation of peptide-chain elongation in mammalian cells. European Journal of Biochemistry 269 5360-5368. (doi:10.1046/j.1432-1033.2002.03290.x)
4. Browne GJ, Finn SG & Proud CG 2004 Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. Journal of Biological Chemistry 279 12220-12231. (doi:10.1074/jbc.M309773200)
5. Cai Y,Wang Q, Ling Z, Pipeleers D, McDermott P, Pende M, Heimberg H & Van de Casteele M 2008 Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR. Biochemical Pharmacology 75 1981-1993. (doi:10.1016/j.bcp.2008.02.019)
6. Cheng SW, Fryer LG, Carling D & Shepherd PR 2004 Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. Journal of Biological Chemistry 279 15719-15722. (doi:10.1074/jbc. C300534200) (Pubitemid 38509255)
7. Cusi K & Defronzo RA 1998 Metformin: a review of its metabolic effects. Diabetes Reviews 6 89-131. (Pubitemid 28554676)
8. Dowling RJ, Zakikhani M, Fantus IG, Pollak M & Sonenberg N 2007 Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Research 67 10804-10812. (doi:10.1158/0008-5472.CAN-07-2310)
9. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M & Leverve X 2000 Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. Journal of Biological Chemistry 275 223-228. (doi:10.1074/jbc.275.1.223) (Pubitemid 30038975)
10. Garcia-Barrado MJ, Ravier MA, Rolland JF, Gilon P, Nenquin M& Henquin JC 2001 Inhibition of protein synthesis sequentially impairs distinct steps of stimulus-secretion coupling in pancreatic beta cells. Endocrinology 142 299-307. (doi:10.1210/en.142.1.299)
11. Gingras AC, Raught B & Sonenberg N 2001 Regulation of translation initiation by FRAP/mTOR. Genes and Development 15 807-826. (doi:10.1101/gad. 887201)
12. Gleason CE, Lu D, Witters LA, Newgard CB & Birnbaum MJ 2007 The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells. Journal of Biological Chemistry 282 10341-10351. (doi:10.1074/jbc.M610631200)
13. Gwinn DM, Shackelford DB, Egan DF,Mihaylova MM, Mery A, Vasquez DS, Turk BE & Shaw RJ 2008 AMPK phosphorylation of raptor mediates a metabolic checkpoint. Molecular Cell 30 214-226. (doi:10.1016/j.molcel.2008.03.003) (Pubitemid 351626684)
14. Henquin JC 1987 Regulation of insulin release by ionic and electrical events in B cells. Hormone Research 27 168-178. (doi:10.1159/000180806)
15. Hinke SA, Martens GA, Cai Y, Finsi J, Heimberg H, Pipeleers D & Van de Casteele M 2007 Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer. British Journal of Pharmacology 150 1031-1043. (doi:10.1038/sj.bjp.0707189)
16. Hoorens A, Van de Casteele M, Kloppel G & Pipeleers D 1996 Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. Journal of Clinical Investigation 98 1568-1574. (doi:10.1172/JCI118950)
17. Inoki K, Zhu T & Guan KL 2003 TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 577-590. (doi:10.1016/S0092- 8674(03)00929-2)
18. Inoki K, Ouyang H, Li Y & Guan KL 2005 Signaling by target of rapamycin proteins in cell growth control. Microbiology and Molecular Biology Reviews 69 79-100. (doi:10.1128/MMBR.69.1.79-100.2005)
19. Kefas BA, Cai Y, Ling Z, Heimberg H, Hue L, Pipeleers D & Van de Casteele M 2003 AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. Journal of Molecular Endocrinology 30 151-161. (doi:10.1677/jme.0.0300151) (Pubitemid 36592509)
20. Kefas BA, Cai Y, Kerckhofs K, Ling Z, Martens G, Heimberg H, Pipeleers D & Van de Casteele M 2004 Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis. Biochemical Pharmacology 68 409-416. (doi:10.1016/j.bcp.2004.04. 003)
21. Kwon G, Marshall CA, Pappan KL, Remedi MS & McDaniel ML 2004 Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes 53 (Supplement 3) S225-S232. (doi:10.2337/diabetes.53.suppl-3.S225)
22. Kwon G, Marshall CA, Liu H, Pappan KL, Remedi MS & McDaniel ML 2006 Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels: effects on cell cycle progression in rodent islets. Journal of Biological Chemistry 281 3261-3267. (doi:10.1074/jbc.M508821200)
23. Leclerc I, Woltersdorf WW, da Silva Xavier G, Rowe RL, Cross SE, Korbutt GS, RajotteRV, SmithR& Rutter GA 2004Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. American Journal of Physiology. Endocrinology and Metabolism 286 E1023-E1031. (doi:10.1152/ajpendo.00532.2003)
24. Leibowitz G, Cerasi E & Ketzinel-Gilad M 2008 The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes. Diabetes, Obesity and Metabolism 10 (Supplement 4) 157-169. (doi:10.1111/j.1463-1326.2008.00952.x)
25. Ling Z & Pipeleers DG 1994 Preservation of glucose-responsive islet beta-cells during serum-free culture. Endocrinology 134 2614-2621. (doi:10.1210/en.134.6.2614) (Pubitemid 24170878)
26. Ling Z, Kiekens R, Mahler T, Schuit FC, Pipeleers-Marichal M, Sener A, Kloppel G, Malaisse WJ & Pipeleers DG 1996 Effects of chronically elevated glucose levels on the functional properties of rat pancreatic betacells. Diabetes 45 1774-1782. (doi:10.2337/diabetes.45.12.1774) (Pubitemid 26398959)
27. Ling Z, Chen MC, Smismans A, Pavlovic D, Schuit F, Eizirik DL & Pipeleers DG 1998 Intercellular differences in interleukin 1beta-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic beta-cells. Endocrinology 139 1540-1545. (doi:10.1210/en.139. 4.1540) (Pubitemid 28513807)
28. Ling Z, Wang Q, Stange G, In't Veld P & Pipeleers D 2006 Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity. Diabetes 55 78-85. (doi:10.2337/diabetes.55.01.06.db05-0820)
29. McDaniel ML, Marshall CA, Pappan KL & Kwon G 2002 Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic beta-cells. Diabetes 51 2877-2885. (doi:10.2337/diabetes.51.10.2877)
30. Owen MR, Doran E & Halestrap AP 2000 Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal 348 607-614. (doi:10.1042/0264-6021: 3480607) (Pubitemid 30410251)
31. Patel J, Wang X & Proud CG 2001 Glucose exerts a permissive effect on the regulation of the initiation factor 4E binding protein 4E-BP1. Biochemical Journal 358 497-503. (doi:10.1042/0264-6021:3580497)
32. Pipeleers DG, Marichal M & Malaisse WJ 1973 The stimulus-secretion coupling of glucose-induced insulin release. XIV. Glucose regulation of insular biosynthetic activity. Endocrinology 93 1001-1011. (doi:10.1210/endo-93-5-1001)
33. Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC & Gepts W 1985 A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117 806-816. (doi:10.1210/endo-117-3-806)
34. Proks P, Reimann F, Green N, Gribble F & Ashcroft F 2002 Sulfonylurea stimulation of insulin secretion. Diabetes 51 (Supplement 3) S368-S376. (doi:10.2337/diabetes.51.2007.S368)
35. Raught B, Gingras AC & Sonenberg N 2001 The target of rapamycin (TOR) proteins. PNAS 98 7037-7044. (doi:10.1073/pnas.121145898)
36. Rutter GA & Leclerc I 2009 The AMP-regulated kinase family: enigmatic targets for diabetes therapy. Molecular and Cellular Endocrinology 297 41-49. (doi:10.1016/j.mce.2008.05.020)
37. Rutter GA, Da Silva Xavier G & Leclerc I 2003 Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochemical Journal 375 1-16. (doi:10.1042/BJ20030048) (Pubitemid 37255376)
38. Schatz H, Katsilambros N, Nierle C & Pfeiffer EE 1972 The effect of biguanides on secretion and biosynthesis of insulin in isolated pancreatic islets of rats. Diabetologia 8 402-407. (doi:10.1007/BF01212167)
39. Schuit FC, In't Veld PA & Pipeleers DG 1988 Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. PNAS 85 3865-3869. (doi:10.1073/pnas.85.11.3865)
40. Schuit FC, Kiekens R & Pipeleers DG 1991 Measuring the balance between insulin synthesis and insulin release. Biochemical and Biophysical Research Communications 178 1182-1187. (doi:10.1016/0006-291X(91)91017-7)
41. Sturgess NC, Ashford ML, Cook DL & Hales CN 1985 The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 2 474-475. (doi:10.1016/S0140-6736(85)90403-9)
42. Wang Q, Heimberg H, Pipeleers D & Ling Z 2008 Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways. Diabetologia 51 1202-1212. (doi:10.1007/s00125-008- 1026-8)
43. Wiernsperger NF 1999 Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes. Diabetes and Metabolism 25 110-127.
44. Wilcock C & Bailey CJ 1991 Reconsideration of inhibitory effect of metformin on intestinal glucose absorption. Journal of Pharmacy and Pharmacology 43 120-121.
45. Williamson DL, Bolster DR, Kimball SR & Jefferson LS 2006 Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR. American Journal of Physiology. Endocrinology and Metabolism 291 E80-E89. (doi:10.1152/ajpendo.00566.2005)
46. Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WGt, Schlattner U, Neumann D, Brownlee M, Freeman MB & Goldman MH 2004 Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. Journal of Biological Chemistry 279 43940-43951. (doi:10.1074/jbc.M404421200)